B
Bindu Chamarthi
Researcher at Brigham and Women's Hospital
Publications - 30
Citations - 1378
Bindu Chamarthi is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Type 2 diabetes & Diabetes mellitus. The author has an hindex of 16, co-authored 29 publications receiving 1177 citations. Previous affiliations of Bindu Chamarthi include Boston University & Harvard University.
Papers
More filters
Journal ArticleDOI
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.
Simon W Dubrey,K. Cha,Jennifer J. Anderson,Bindu Chamarthi,Johann Reisinger,Martha Skinner,Rodney H. Falk +6 more
TL;DR: It should be suspected in all patients with heart failure who have wall thickening on echo, normal chamber sizes, low EKG voltages and evidence suggesting a multisystem disease, and most frequently patients had features of multiorgan dysfunction; heavy proteinuria and features of mal absorption predominating in this respect.
Journal ArticleDOI
Preoperative A1C and Clinical Outcomes in Patients With Diabetes Undergoing Major Noncardiac Surgical Procedures
TL;DR: It is suggested that chronic hyperglycemia (A1C >8%) is associated with poor surgical outcomes (longer hospital LOS), and providing a preoperative intervention to improve glycemic control in individuals with A1C values >8% may improve surgical outcomes.
Journal ArticleDOI
Inflammation and Hypertension: The Interplay of Interleukin-6, Dietary Sodium, and the Renin–Angiotensin System in Humans
Bindu Chamarthi,Gordon H. Williams,Vincent Ricchiuti,Nadarajah Srikumar,Paul N. Hopkins,James M. Luther,Xavier Jeunemaitre,Xavier Jeunemaitre,Abraham Thomas +8 more
TL;DR: Findings confirm an association between hypertension and inflammation and provide human data supporting previous evidence from animal studies that IL-6 plays a role in angiotensin II-mediated hypertension.
Journal ArticleDOI
Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis
TL;DR: Stress-precipitated syncope was associated with a poor prognosis in patients with AL amyloid heart disease, both in terms of their median survival of 2 months and was frequently a precursor of sudden cardiac death.
Journal ArticleDOI
Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus.
Geoffrey A. Walford,Jaclyn Davis,A. Sofia Warner,Rachel J. Ackerman,Liana K. Billings,Bindu Chamarthi,Bindu Chamarthi,Rebecca R. Fanelli,Alicia M. Hernandez,Chunmei Huang,Sabina Q. Khan,Katherine R. Littleton,Janet Lo,Rita M. McCarthy,Rita M. McCarthy,Eugene P. Rhee,Eugene P. Rhee,Amy Deik,Elliot S. Stolerman,Andrew W. Taylor,Margo S. Hudson,Margo S. Hudson,Thomas J. Wang,David Altshuler,Richard W. Grant,Clary B. Clish,Robert E. Gerszten,Robert E. Gerszten,Jose C. Florez +28 more
TL;DR: BCAA/AAAs changed acutely during glipizide and metformin administration, and the magnitude and direction of change differed by the insulin resistance status of the individual and the intervention, indicating that BCAA/ AAAs may be useful biomarkers for monitoring the early response to therapeutic interventions for T2D.